Topic
China Tariff Review for U.S. Importers
Review China-origin tariff exposure across Section 301, AD/CVD, exclusions, HTS lines, and source-backed records.
China originHTS linesSection 301AD/CVDexclusions
Search intent
People search for China tariffs for U.S. importers.
This page is the public entry point. It explains the issue, links to the public tools that surface the primary records, and routes repeat work into review.
Search paths
Split the China tariff question before reviewing records.
Review path
Move from public China tariff records to repeat review.
- 1Start publicRead the public source record, tariff context, and related path before deciding whether the issue matters to an operating import scope.
- 2Define the repeat scopeKeep the HTS line, China origin, supplier or product family, authority, and exclusion or case terms together when the same question repeats.
- 3Review when records moveUse the review workflow (free with an account) when a new source record, effective date, exclusion change, or case event needs full tool output, AD/CVD detail, or source-backed PDF/CSV export.
Review China-origin scopeWhy it matters
China-origin exposure often sits across several layers at once: base duty, Section 301, AD/CVD risk, exclusion status, and new source records. A single public notice can change the next review question for a product line.
How Traverse frames it
Traverse treats China tariff work as a source-backed memo problem. Public pages show the source layer; a free account keeps repeated HTS, origin, authority, and case questions together.
Common questions
What import teams usually need to answer.
How should importers review China tariff changes?
Start with the HTS line and origin, then watch Section 301 actions, exclusion status, AD/CVD case activity, and Federal Register or agency records that can change the duty stack.
Is a China tariff check only a rate lookup?
No. A rate lookup is only one layer. Import teams usually need the source record, effective date, authority, product scope, and any exclusion or remedy context beside the rate.
What should be reviewed for repeated China-origin review?
Keep the HTS line, China-origin posture, supplier or product family terms, Section 301 list or exclusion terms, and any case or agency source together when the question repeats.
Review checklist
What to check before this becomes repeat review.
- 1Confirm the HTS line and product description.
- 2Check whether China origin creates a Section 301 layer.
- 3Look for exclusion, extension, or expiration records.
- 4Check AD/CVD and injury-case signals for the same product family.
- 5Review repeated HTS, origin, authority, and case terms as scope.
ExecutiveAug 14, 2026Federal Register
AD/CVD Orders on Carbazole Violet Pigment 23 from China & India Revoked, Sunset Reviews Terminated
Commerce revoked the CVD order on carbazole violet pigment 23 from India and AD orders from China and India effective August 7, 2026, after no domestic party filed a timely notice of intent to participate in the fourth sunset reviews. The USITC has consequently terminated investigation Nos. 701-TA-437 and 731-TA-1060-1061.
ExecutiveAug 13, 2026Federal Register
USITC Preliminary AD/CVD Determinations: Choline Salts from China (Inv. 701-TA-798 & 731-TA-1794)
The USITC issued preliminary affirmative determinations in countervailing duty (Inv. 701-TA-798) and antidumping duty (Inv. 731-TA-1794) investigations covering choline salts from China. Affirmative preliminary findings allow the investigations to proceed to the Commerce Department for duty calculations.
JudicialAug 13, 2026U.S. District Court for the District of Columbia
YMTC Sues Micron in D.C. Federal Court, China Semiconductor IP Dispute
Yangtze Memory Technologies (YMTC), a Chinese NAND flash manufacturer on the U.S. Entity List, has filed suit against Micron Technology in the U.S. District Court for the District of Columbia. The case intersects U.S.-China semiconductor trade tensions and may implicate export control and IP enforcement dynamics.
Track China-origin HTS lines across Section 301, AD/CVD, and exclusions. Review China-origin scope.